Stewart Stacey D. 4

What Happened

• Stacey D. Stewart, a director of Hologic Inc. (HOLX), was granted 3,190 restricted stock units (RSUs) on February 26, 2026 (transaction code A = Award/Grant). No per-share price is reported (N/A) because this is a compensation award rather than an open-market trade. The RSUs vest on the date of the 2027 Annual Meeting of Stockholders and will be settled in common shares on a one-for-one basis.

Key Details

• Transaction date: 2026-02-26; Form 4 filed: 2026-03-02.
• Award amount: 3,190 RSUs; price: N/A (compensation grant).
• Vesting/settlement: Vest on 2027 Annual Meeting; settled 1-for-1 in common stock (per footnotes F1 & F2).
• Footnote F3: filing notes inclusion of 3,436 RSUs whose settlement has been deferred under the issuer’s Deferred Equity Plan (these deferred RSUs are separate disclosure of holdings/deferrals).
• Shares owned after the transaction: not specified in the provided data.
• Timeliness: The Form 4 was filed on 2026-03-02 for a 2026-02-26 grant; this appears to be later than the typical two-business-day Form 4 filing requirement.

Context

• This was a compensation award (RSUs) to a director — not a purchase or sale in the open market — so there was no immediate cash flow or share sale. RSU grants are common for director compensation and do not by themselves indicate the director’s short-term trading intent. The RSUs will convert to shares only after vesting and any deferred settlement elections are honored.